September Quarterly Activity and Cashflow Report
Filed with ASX · · 10 pages · English
Story so far
Earlier from Argent Biopharma
- Mgc pharma delivers record consecutive weekly sales growth
- ArtemiC histology on rats confirm no pathological impact
- First high THC products shipped direct to Brazil patients
- MGC pharma launches CannEpil app
- Update on ArtemiC phase II trial on COVID-19 patients
Later from Argent Biopharma
- Completion of phase II clinical trial on COVID-19 patients
- Further successful results from glioblastoma research
- MGC pharma completes acquisition of telehealth platform MCC
- Prospectus
- ArtemiC Phase II Clinical Trial Results
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma